Table 3 Specific viral reactivation and VAP
VAP in patients with viral reactivation | Viral reactivation without VAP | VAP without reactivation | P value | |
|---|---|---|---|---|
CMV, 73 patients | 44 (70%) | 29 (40%) | 19 (30%) | 0.034 |
EBV, 78 patients | 45 (71%) | 33 (42%) | 18 (43%) | 0.122 |
HSV-1, 58 patients | 34 (54%) | 24 (41%) | 29 (46%) | 0.196 |
HSV-2, 3 patients | 3 (4.8%) | 0 (0.0%) | 60 (95%) | 0.097 |